ESC Professional Premium Access

Does first line atrial fibrillation ablation improve survival in HFrEF?

Congress Session

About the speaker

Associate Professor Jonathan Piccini

Duke University Medical Center, Durham (United States of America)
4 presentations
0 follower

4 more presentations in this session

Does first line atrial fibrillation ablation improve survival in HFpEF?

Speaker: Professor G. Hindricks (Leipzig, DE)

Thumbnail

Does first line AF ablation improve outcome in hypertrophic cardiomyopathy patients?

Speaker: Doctor A. Creta (London, GB)

Thumbnail

Does first line AF ablation improve outcome in asymptomatic patients?

Speaker: Professor K. Chun (Frankfurt am Main, DE)

Thumbnail

When to consider AF ablation: outcome and survival in specific cohorts – discussion.

Thumbnail

Access the full session

When to consider AF ablation: outcome and survival in specific cohorts

Speakers: Associate Professor J. Piccini, Professor G. Hindricks, Doctor A. Creta, Professor K. Chun
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk